INFLUVAC TETRA (Mylan Health Pty Ltd)
Product name
INFLUVAC TETRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
201 working days (255)
Active ingredients
influenza virus haemagglutinin
Registration type
EOI
Indication
INFLUVAC TETRA (prefilled syringe) is indicated for the prevention of influenza caused by influenza virus, types A and B. For full details regarding recommendations for influenza vaccination, please refer to the relevant National Immunisation Guidelines.
INFLUVAC TETRA is now indicated in adults and children from 3 years of age and older.